Rafael

RFLNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$104.000 M

$2.00 +0.00%

Close of 22 Sept 2026

Revenue

$917.0K

#3486 by revenue

Earnings

-$30.5M

Loss-making

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#306Rani TherapeuticsRANI$108.4M
#307Polaryx TherapeuticsPLYX$107.2M
#308RafaelRFL$104.0M
#309BGM GroupBGM$103.3M
#310Neonc TechnologiesNTHI$102.7M

What if Rafael were worth as much as…

Open the what-if tool →

Gold $30.2T

$581,422.54

Per share 290,711× higher

Bitcoin $1.74T

$33,493.37

Per share 16,747× higher

Nvidia $5.52T

$106,072.45

Per share 53,036× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for Rafael are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.